Search research articles
Contact Us
Filters
Showing results (61-70 of 86) with videos related to
Page
of 9
Sort By:
Journal of Asthma and Allergy
|
June 14, 2022
Efficacy and Safety of Masitinib in Corticosteroid-Dependent Severe Asthma: A Randomized Placebo-Controlled Trial
Lavinia Davidescu, Grigoriy Ursol, Oleksii Korzh, et al.
Frontiers in Medicine
|
April 8, 2024
Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis
Charlene Desaintjean, Kaïs Ahmad, Julie Traclet, et al.
ERJ Open Research
|
February 27, 2024
Articular manifestations related to anti-interleukin-5 therapies in severe asthma: a case series
Clairelyne Dupin, Solène Valéry, Laurent Guilleminault, et al.
Journal of Asthma and Allergy
|
April 10, 2024
Benralizumab in Severe Eosinophilic Asthma and Chronic Rhinosinusitis with Nasal Polyps: The Real-World, Multi-Country RANS Observational Study
Tham T Le, Benjamin Emmanuel, Rohit Katial, et al.
International Journal of Antimicrobial Agents
|
October 7, 2021
Azole resistance in Aspergillus fumigatus isolates from respiratory specimens in Lyon University Hospitals, France: prevalence and mechanisms involved
Loïc Simon, Tanguy Déméautis, Damien Dupont, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 25, 2026
Switching to twice-yearly depemokimab from mepolizumab/benralizumab in severe asthma: A multicenter, randomized, double-blind, Phase 3A Clinical Trial (NIMBLE)
Geoffrey Chupp, Hiroyuki Nagase, Dirk Skowasch, et al.
Chest
|
April 13, 2013
A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthma
Gilles Garcia, Antoine Magnan, Raphaël Chiron, et al.
Orphanet Journal of Rare Diseases
|
December 5, 2016
Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohort
Yves Pacheco, Alain Calender, Dominique Israël-Biet, et al.
Free Radical Biology & Medicine
|
August 10, 2018
An elastase activity reporter for Electronic Paramagnetic Resonance (EPR) and Overhauser-enhanced Magnetic Resonance Imaging (OMRI) as a line-shifting nitroxide
Natacha Jugniot, Indranil Duttagupta, Angélique Rivot, et al.
Pediatric Blood & Cancer
|
July 21, 2009
Is pegfilgrastim safe and effective in congenital neutropenia? An analysis of the French Severe Chronic Neutropenia registry
Blandine Beaupain, Thierry Leblanc, Oumédaly Reman, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 86) with videos related to
Sort By:
Page
of 9
Journal of Asthma and Allergy
|
June 14, 2022
Efficacy and Safety of Masitinib in Corticosteroid-Dependent Severe Asthma: A Randomized Placebo-Controlled Trial
Lavinia Davidescu, Grigoriy Ursol, Oleksii Korzh, et al.
Frontiers in Medicine
|
April 8, 2024
Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis
Charlene Desaintjean, Kaïs Ahmad, Julie Traclet, et al.
ERJ Open Research
|
February 27, 2024
Articular manifestations related to anti-interleukin-5 therapies in severe asthma: a case series
Clairelyne Dupin, Solène Valéry, Laurent Guilleminault, et al.
Journal of Asthma and Allergy
|
April 10, 2024
Benralizumab in Severe Eosinophilic Asthma and Chronic Rhinosinusitis with Nasal Polyps: The Real-World, Multi-Country RANS Observational Study
Tham T Le, Benjamin Emmanuel, Rohit Katial, et al.
International Journal of Antimicrobial Agents
|
October 7, 2021
Azole resistance in Aspergillus fumigatus isolates from respiratory specimens in Lyon University Hospitals, France: prevalence and mechanisms involved
Loïc Simon, Tanguy Déméautis, Damien Dupont, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 25, 2026
Switching to twice-yearly depemokimab from mepolizumab/benralizumab in severe asthma: A multicenter, randomized, double-blind, Phase 3A Clinical Trial (NIMBLE)
Geoffrey Chupp, Hiroyuki Nagase, Dirk Skowasch, et al.
Chest
|
April 13, 2013
A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthma
Gilles Garcia, Antoine Magnan, Raphaël Chiron, et al.
Orphanet Journal of Rare Diseases
|
December 5, 2016
Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohort
Yves Pacheco, Alain Calender, Dominique Israël-Biet, et al.
Free Radical Biology & Medicine
|
August 10, 2018
An elastase activity reporter for Electronic Paramagnetic Resonance (EPR) and Overhauser-enhanced Magnetic Resonance Imaging (OMRI) as a line-shifting nitroxide
Natacha Jugniot, Indranil Duttagupta, Angélique Rivot, et al.
Pediatric Blood & Cancer
|
July 21, 2009
Is pegfilgrastim safe and effective in congenital neutropenia? An analysis of the French Severe Chronic Neutropenia registry
Blandine Beaupain, Thierry Leblanc, Oumédaly Reman, et al.
Page
of 9